FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Barclays to sell Entercard stake to Swedbank

Barclays PLC has agreed to sell its entire shareholding in Entercard Group AB to joint venture partner Swedbank AB for an estimated SEK2.6 billion in cash...

Smiths Group Plc announces Board and Committee changes ahead of AGM

Smiths Group has confirmed a series of Board and Committee changes as part of its succession planning. Mark Seligman, Noel Tata and Karin Hoeing will retire following the AGM on 19 November 2025. Dame Ann Dowling will become Senior Independent Director, while Alister Cowan will chair the Remuneration & People Committee. Pam Cheng will join the Audit & Risk Committee...

British American Tobacco Plc CFO Soraya Benchikh to step down

British American Tobacco has announced that Chief Financial Officer Soraya Benchikh will step down from her role and the Board on 26 August 2025, remaining until year-end to support the transition. Javed Iqbal, currently Director of Digital and Information, will take over as interim CFO while a search for a permanent successor begins...

Bunzl Plc expands with five acquisitions across Spain, Mexico, Brazil and Chile

Bunzl has announced the completion of two new acquisitions, Quindesur in Spain and Gisa in Mexico, alongside the previously disclosed purchases of Solupack in Brazil and Hospitalia in Chile...

United Utilities signs £3bn deal to refurbish Haweswater Aqueduct

United Utilities has agreed a £3 billion programme to upgrade the 110km Haweswater aqueduct, which supplies water to 2.5 million people across Greater Manchester and Lancashire...

Pershing Square Holdings reports 15.5% NAV growth in H1 2025

Pershing Square Holdings delivered a 15.5% NAV increase in the six months to 30 June 2025, outperforming the S&P 500’s 6.2% return. Year-to-date through 19 August, NAV rose 17.7% with a 16.5% share price gain...

LondonMetric raises quarterly dividend by 7% to 3.05p

LondonMetric has declared a 7% increase in its first quarterly interim dividend for FY 2025/26 to 3.05 pence per share, payable as a Property Income Distribution. The dividend will be paid on 8 October 2025, with an ex-dividend date of 28 August 2025 and a scrip alternative available...

Convatec Group Plc launches $300m share buyback programme

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31 December 2025 and aims to reduce the company’s share capital, with purchased shares either cancelled or held in treasury for employee plans...

Babcock International appoints Aedamar Comiskey as Non-Executive Director

Babcock International has announced the appointment of Aedamar Comiskey as a Non-Executive Director, effective 1 September 2025. She will serve on the Nominations, Audit and Remuneration committees, bringing extensive corporate law and board experience from her leadership roles at Linklaters and James Fisher and Sons plc...

Landsec sells Queen Anne’s Mansions office block for £245m

Landsec has agreed the £245m unconditional sale of its Queen Anne’s Mansions office block in SW1 to Arora Group. The deal, which crystallises redevelopment value and delivers an immediate uplift to return on equity, marks early progress towards Landsec’s plan to release £2bn from offices by 2030...

Associated British Foods to acquire Hovis Group

Associated British Foods has agreed to acquire Hovis Group from Endless LLP, combining it with Allied Bakeries to form a more efficient and sustainable UK bread business...

Antofagasta Plc delivers 60% EBITDA growth in H1 2025

Antofagasta plc reported a 60% rise in EBITDA to $2.23 billion for the first half of 2025, with margins up 12 percentage points to 58.8% and underlying earnings per share more than doubling to 47.4 cents...

National Grid Plc to sell Grain LNG for £1.66 billion

National Grid plc has agreed to sell its Grain LNG business to a consortium comprising Centrica plc and Energy Capital Partners LLC for approximately £1.66 billion, including a pre-completion dividend...

Diploma Plc CFO resigns over conduct

Diploma PLC announced the immediate resignation of Chief Financial Officer Chris Davies following a lapse in personal conduct at a recent company event. The decision is unrelated to financial performance, and FY25 guidance remains unchanged...

Unite Group to acquire Empiric in £723 million cash and share deal

Unite Group has agreed to acquire Empiric Student Property plc in a recommended cash and share offer valuing the company at approximately £723 million, including dividends. The deal will create a £10.5 billion UK student accommodation portfolio...

Entain H1 2025 results beat expectations, FY guidance upgraded

Entain plc reported a 7% rise in total group net gaming revenue for H1 2025, including a 35% constant currency increase from BetMGM. Online performance exceeded forecasts, with UK & Ireland up 21% and Brazil up 21%...

Spirax Group Plc reports organic growth and dividend increase in H1 results

Spirax Group reported half-year revenue of £822.2m, down 1% reported but up 3% organically, with adjusted operating profit rising 7% organically to £158.8m. Statutory profit was affected by restructuring costs and currency headwinds, while adjusted cash conversion improved to 61%...

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea in patients aged 12 and over...

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech and Pfizer, following a settlement linked to CureVac’s recent agreement with BioNTech...

Hikma Pharmaceuticals reports 6% revenue growth and confirms FY outlook

Hikma Pharmaceuticals posted a 6% rise in H1 2025 revenue to $1.66 billion, supported by strong Injectables and Branded sales. Core operating profit declined 7% due to product mix and prior-year comparators, but the company expects a stronger H2...
Search

Funds

FTSE 100

Barclays to sell Entercard stake to Swedbank

Barclays PLC has agreed to sell its entire shareholding in Entercard Group AB to joint venture partner Swedbank AB for an estimated SEK2.6 billion in cash...

Smiths Group Plc announces Board and Committee changes ahead of AGM

Smiths Group has confirmed a series of Board and Committee changes as part of its succession planning. Mark Seligman, Noel Tata and Karin Hoeing will retire following the AGM on 19 November 2025. Dame Ann Dowling will become Senior Independent Director, while Alister Cowan will chair the Remuneration & People Committee. Pam Cheng will join the Audit & Risk Committee...

British American Tobacco Plc CFO Soraya Benchikh to step down

British American Tobacco has announced that Chief Financial Officer Soraya Benchikh will step down from her role and the Board on 26 August 2025, remaining until year-end to support the transition. Javed Iqbal, currently Director of Digital and Information, will take over as interim CFO while a search for a permanent successor begins...

Bunzl Plc expands with five acquisitions across Spain, Mexico, Brazil and Chile

Bunzl has announced the completion of two new acquisitions, Quindesur in Spain and Gisa in Mexico, alongside the previously disclosed purchases of Solupack in Brazil and Hospitalia in Chile...

United Utilities signs £3bn deal to refurbish Haweswater Aqueduct

United Utilities has agreed a £3 billion programme to upgrade the 110km Haweswater aqueduct, which supplies water to 2.5 million people across Greater Manchester and Lancashire...

Pershing Square Holdings reports 15.5% NAV growth in H1 2025

Pershing Square Holdings delivered a 15.5% NAV increase in the six months to 30 June 2025, outperforming the S&P 500’s 6.2% return. Year-to-date through 19 August, NAV rose 17.7% with a 16.5% share price gain...

LondonMetric raises quarterly dividend by 7% to 3.05p

LondonMetric has declared a 7% increase in its first quarterly interim dividend for FY 2025/26 to 3.05 pence per share, payable as a Property Income Distribution. The dividend will be paid on 8 October 2025, with an ex-dividend date of 28 August 2025 and a scrip alternative available...

Convatec Group Plc launches $300m share buyback programme

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31 December 2025 and aims to reduce the company’s share capital, with purchased shares either cancelled or held in treasury for employee plans...

Babcock International appoints Aedamar Comiskey as Non-Executive Director

Babcock International has announced the appointment of Aedamar Comiskey as a Non-Executive Director, effective 1 September 2025. She will serve on the Nominations, Audit and Remuneration committees, bringing extensive corporate law and board experience from her leadership roles at Linklaters and James Fisher and Sons plc...

Landsec sells Queen Anne’s Mansions office block for £245m

Landsec has agreed the £245m unconditional sale of its Queen Anne’s Mansions office block in SW1 to Arora Group. The deal, which crystallises redevelopment value and delivers an immediate uplift to return on equity, marks early progress towards Landsec’s plan to release £2bn from offices by 2030...

Associated British Foods to acquire Hovis Group

Associated British Foods has agreed to acquire Hovis Group from Endless LLP, combining it with Allied Bakeries to form a more efficient and sustainable UK bread business...

Antofagasta Plc delivers 60% EBITDA growth in H1 2025

Antofagasta plc reported a 60% rise in EBITDA to $2.23 billion for the first half of 2025, with margins up 12 percentage points to 58.8% and underlying earnings per share more than doubling to 47.4 cents...

National Grid Plc to sell Grain LNG for £1.66 billion

National Grid plc has agreed to sell its Grain LNG business to a consortium comprising Centrica plc and Energy Capital Partners LLC for approximately £1.66 billion, including a pre-completion dividend...

Diploma Plc CFO resigns over conduct

Diploma PLC announced the immediate resignation of Chief Financial Officer Chris Davies following a lapse in personal conduct at a recent company event. The decision is unrelated to financial performance, and FY25 guidance remains unchanged...

Unite Group to acquire Empiric in £723 million cash and share deal

Unite Group has agreed to acquire Empiric Student Property plc in a recommended cash and share offer valuing the company at approximately £723 million, including dividends. The deal will create a £10.5 billion UK student accommodation portfolio...

Entain H1 2025 results beat expectations, FY guidance upgraded

Entain plc reported a 7% rise in total group net gaming revenue for H1 2025, including a 35% constant currency increase from BetMGM. Online performance exceeded forecasts, with UK & Ireland up 21% and Brazil up 21%...

Spirax Group Plc reports organic growth and dividend increase in H1 results

Spirax Group reported half-year revenue of £822.2m, down 1% reported but up 3% organically, with adjusted operating profit rising 7% organically to £158.8m. Statutory profit was affected by restructuring costs and currency headwinds, while adjusted cash conversion improved to 61%...

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea in patients aged 12 and over...

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech and Pfizer, following a settlement linked to CureVac’s recent agreement with BioNTech...

Hikma Pharmaceuticals reports 6% revenue growth and confirms FY outlook

Hikma Pharmaceuticals posted a 6% rise in H1 2025 revenue to $1.66 billion, supported by strong Injectables and Branded sales. Core operating profit declined 7% due to product mix and prior-year comparators, but the company expects a stronger H2...
Search

Funds

FTSE 100

FTSE 100

Funds